Trial Profile
A study assessing the use of florbetapir-18-F in classifying alzheimer's disease in subjects with or without alzheimer's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 19 Oct 2015 New trial record